Abstract
Background and aims: As HCC remains the leading complication in HBV compensated cirrhotics long-term TDF/ETV treated, we aimed to define baseline predictors of HCC, including the tolloid like 1 gene (TLL1) rs17047200 polymorphism which predicts HCC in HCV patients cured by IFN therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
